Publications
2024
Characteristics and outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177–PSMA-617 (PSMA-RLT) in a real-world setting.
David Kersting, Moon Kim, Lukas Püllen, Kathi Seidl-Rathkopf, Nicole Schinwald, Philani Mpofu, Ivy Altomare, Arun Sujenthiran, Trevor Joseph Royce, Christoph Buhl, Viktor Grünwald, Ken Herrmann, Jens Kleesiek, Boris Hadaschik
Journal of Clinical Oncology 
